Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Female × Tumor Burden × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Thymus Neoplasms 1 Shoulder Disease 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma 1 Margins of Excision 1 Lung Neoplasms 1 Kidney Neoplasms 1 Hernia, Hiatal 1 Gastroesophageal Reflux 1 Esophageal Neoplasms 1 Esophageal Diseases 1 Esophageal Achalasia 1 Craniopharyngioma 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Hepatocellular 1 Breast Cancer Female 1 Adenocarcinoma 1

Interventions

Tamoxifen 4 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04504747 2025-06-15

NEO-R

Institut Paoli-Calmettes

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡